Skip to content
OpenCapital
Get started

Luxfer Holdings LXFR Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Innoviva, Inc. logo
Innoviva, Inc.INVA
36%+7.0pp
Strattec Security logo
Strattec SecuritySTRT
0.5%0.0pp

Segments

By geography

See full
US62.5%—
GB4.9%—
CA4.5%—
DE3.6%—
IN3.6%—
Rest Of The World2.2%—

Other financials

Income statement

See full
Revenue$83.9M-13.5%
Gross profit$22.1M-3.5%
Operating income$3.3M-17.5%
Net income$3.6M-34.5%
EPS (diluted)$0.10-78.7%

Balance sheet

See full
Cash & equivalents$8.3M+31.7%
Total debt$51.6M+147%
Total equity$226.4M+3.1%
Total assets$369.7M-3.3%

Cash flow

See full
Operating cash flow-$4.1M-176%
CapEx$2.0M+66.7%
Free cash flow-$6.1M-245%

Valuation

See full
Market cap$506.1M+64.3%
Enterprise value$549.4M+10.9%
P/E35.2×-17.6×
P/S1.4×+0.6×

Profitability

See full
Gross margin23.2%+1.3pp
Operating margin6.2%-1.4pp
Net margin3.6%+1.2pp
FCF margin4.5%-6.2pp

Returns & leverage

See full
Return on equity6.3%+2.0pp
Debt / equity0.2×+0.1×
Current ratio1.7×-0.2×